CVS Health Corporation $CVS Stock Holdings Lifted by Lido Advisors LLC

Lido Advisors LLC grew its holdings in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 10.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 59,355 shares of the pharmacy operator’s stock after acquiring an additional 5,656 shares during the quarter. Lido Advisors LLC’s holdings in CVS Health were worth $5,086,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the business. Elevation Wealth Partners LLC boosted its stake in shares of CVS Health by 41.8% in the 2nd quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 105 shares in the last quarter. HBW Advisory Services LLC raised its position in CVS Health by 3.5% in the 3rd quarter. HBW Advisory Services LLC now owns 3,408 shares of the pharmacy operator’s stock worth $292,000 after purchasing an additional 115 shares during the period. Apella Capital LLC raised its position in CVS Health by 1.7% in the 2nd quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator’s stock worth $724,000 after purchasing an additional 117 shares during the period. Wellington Altus USA Inc. lifted its stake in CVS Health by 13.3% in the second quarter. Wellington Altus USA Inc. now owns 1,025 shares of the pharmacy operator’s stock worth $106,000 after purchasing an additional 120 shares during the last quarter. Finally, Childress Capital Advisors LLC lifted its stake in CVS Health by 3.9% in the third quarter. Childress Capital Advisors LLC now owns 3,497 shares of the pharmacy operator’s stock worth $300,000 after purchasing an additional 131 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Insider Buying and Selling at CVS Health

In other news, EVP Prem Shah bought 23,855 shares of the company’s stock in a transaction dated Friday, November 6th. The stock was bought at an average cost of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the acquisition, the executive vice president owned 88,516 shares in the company, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.85% of the company’s stock.

CVS Health Stock Up 0.2%

Shares of NYSE CVS opened at $89.69 on Friday. The firm’s fifty day moving average is $89.81 and its 200 day moving average is $89.00. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The company has a market cap of $114.76 billion, a price-to-earnings ratio of 10.44, a PEG ratio of 0.78 and a beta of 0.58.

CVS Health (NYSE:CVS – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.65 by $0.44. The business had revenue of $108.40 billion during the quarter, compared to analysts’ expectations of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The firm’s revenue for the quarter was up 5.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.60 EPS. On average, equities research analysts expect that CVS Health Corporation will post 8.26 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were paid a dividend of $0.6650 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s dividend payout ratio is 30.97%.

Top CVS Health Stories

Investors following CVS have been watching these stories:

  • Positive Sentiment: CVS reported quarterly adjusted earnings of $2.09 per share, beating the $1.65 consensus estimate, while revenue rose 5.4% year over year to $108.4 billion. The earnings beat and growth support the case for improved operating performance. Article: CVS Beat Earnings by 27% and Split in Two
  • Neutral Sentiment: Wells Fargo’s price-target cut signals more cautious valuation assumptions, though its continued overweight rating indicates the analyst remains positive on CVS. Article: Wells Fargo rating and price target
  • Negative Sentiment: The split is not a guaranteed catalyst: coverage highlights separation costs and execution risks, while Aetna’s recovery and stronger pharmacy profits are weighed against PBM pressures and declining membership. Senator Elizabeth Warren has also criticized the plan, suggesting political scrutiny may continue. Article: Is CVS Stock Worth Buying as Aetna Recovers but PBM Risks Persist?

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CVS. Barclays cut their price target on shares of CVS Health from $108.00 to $107.00 and set an “overweight” rating for the company in a research report on Thursday, November 5th. Weiss Ratings upgraded CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday. Wall Street Zen downgraded CVS Health from a “strong-buy” rating to a “buy” rating in a report on Monday, October 19th. Raymond James Financial set a $103.00 target price on CVS Health in a research note on Friday, November 6th. Finally, Leerink Partners dropped their target price on CVS Health from $112.00 to $104.00 and set an “outperform” rating for the company in a report on Thursday, November 5th. Twenty-three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $107.79.

Get Our Latest Stock Analysis on CVS

CVS Health Profile

(Free Report)

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Recommended Stories

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.